AML-M1 or -M4, or myelodysplastic syndrome (MDS) had leukemia subtype M2 (AML-M2) patients with t(8;21) were comt(8;21), 3 there were no such cases in our series.
tory of preceding MDS or of receiving radiotherapy or chemotherapy for other malignant diseases were not included. Forty of the 80 patients examined were registered for the Japan Introduction Adult Leukemia Study Group (JLSG) AML-87 protocol.
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Cytogenetic analyses with quinacrine fluorescent and acetic It is now well established that specific chromosome abnorsaline Giemsa banding techniques were performed on BM malities are closely associated with particular subtypes of cells obtained at the time of diagnosis. We examined cells acute myeloid leukemia (AML) showing characteristic morfrom direct preparations or from 24 or 48 h unstimulated culphologic and clinical features. The best known examples are tures. Patients were considered to have a normal karyotype t(8;21)(q22;q22), t(15;17)(q22;q21), and inv(16)(p13q22) in when at least 20 metaphase cells were examined and an AMLs with subtypes M2, M3 and M4Eo, respectively. 1 Since abnormal karyotype was not detected. virtually all patients diagnosed as having M3 and M4Eo exhi-BM smears were stained using conventional May-Grü nbit t(15;17) and inv(16), respectively, it is possible to predict wald-Giemsa and MPO methods, and were observed by three with high accuracy the presence of these chromosome abnorexpert hematologists (HN, KK and MT) to evaluate the mormalities by the morphologic observations of leukemia cells.
phologic and cytochemical features of the BM cells. MicroHowever, only 30-40% of all M2 patients have t(8,21). Since scopic observation was done without the knowledge of chro-AML patients with this chromosome anomaly have been mosome features of each patient. The percentages of Auer reported to have some characteristic morphologic features, 1, 2 bodies and of MPO positivity were based on a count of 200 recognition of these features may alert us to the possibility of blast cells, and Auer bodies were considered to be present the presence of t(8;21) before cytogenetic results are obtained.
when they were observed in at least 0.5% of the blast cells. In this report, the morphologic and cytochemical features of Blast cell size was considered to be heterogeneous when there 80 AML-M2 patients were evaluated in detail, and compared were at least 5% large blast cells with a cell diameter which between patients with t(8;21) and those without this chromowas at least one and a half times as long as that of small blast some abnormality. Although some reports have shown that a cells. The nuclear shape of blast cells was considered to be very small number of patients who were diagnosed as having irregular when 25% or more of the blast cells had irregular nuclear contours due to the presence of indentations and lobulations. For the presence of dysplastic features in megakary- (TLD) were applied. 6 The cytoplasm of mature neutrophils was considered to be homogeneous pink or pale without any ratio. The white cell count of the t(8;21) + patients was also significantly lower than that of the t(8;21) − patients (mean granules when at least 25% of mature neutrophils revealed the feature in at least a 20 cell count. Pseudo-Pelger-Huët 13.8 × 10 9 vs 28.3 × 10 9 /l, P Ͻ 0.05). There was no difference in the percentage of blast cells in the white cells of the two anomaly and MPO deficiency of mature neutrophils were considered to be present when at least 3% and 1% of the cells groups.
Intensive remission induction chemotherapy with standardobserved showed these findings, respectively. The percentage of BM eosinophils was based on a count of 500 nucleated BM dose Ara-C plus anthracycline was performed for 29 of the t(8;21) + patients and 45 of the t(8;21) − patients; the remaining cells. Dyserythropoietic features were considered to be present when at least 25% of the erythroblasts showed dyspatients were treated with low-dose Ara-C or managed by supportive care only. As a result, the former group revealed a plastic features, ie megaloblastoid change, multi-nuclearity, and karyorrhexis, in a 100 erythroid cell count. For some significantly higher complete remission (CR) rate than the latter group (100 vs 64%, P Ͻ 0.01). Both the duration of CR and patients, the neutrophil alkaline phosphatase (NAP) score in the peripheral blood was counted according to a previously survival were significantly longer in the t( 
Morphologic and cytochemical features
groups were done using the Mann-Whitney U test. The Kaplan-Meier procedure was performed to determine disease-
The morphologic and cytochemical features, the incidences of which were significantly (P Ͻ 0.05) different between free survival (DFS) and overall survival. For comparison of DFS and overall survival, generalized Wilcoxon and log rank t(8;21) + and t(8;21) − groups, are listed in Table 2 . Heterogeneity in size, irregularity of nuclear shape, Auer bodies, and tests were used. more than 90% MPO positivity in myeloblasts, and homogeneous pink-colored cytoplasm and pseudo-Pelger-Huët anomaly of nuclei in mature neutrophils were observed in Results most or all (90-100%) of the t(8,21) + patients ( Figure 1 ). The incidences of these features were significantly higher than in
Cytogenetic features the t(8;21)
− patients. Conversely, pale-colored cytoplasm without any granules in mature neutrophils and dyserythropoOf the 80 patients examined, 30 (37.5%) revealed t(8;21), 30 (37.5%) a normal karyotype, and the remaining 20 (25%) ietic features were observed in 76% and 44% of the t(8;21) − patients ( Figure 2 ), respectively, but were not seen in any abnormal karyotypes other than t(8;21). Among the last patients, eight had balanced chromosome abnormalities such t(8;21) + patients. The difference in the incidences of these morphologic features was also significant. as t(3;5)(q25;q34) and t(11;19)(q23;p13), nine unbalanced ones such as del(7q) and +8, and the remaining three both
The incidence of MPO-negative mature neutrophils in the t(8;21)
+ group was significantly lower than that in the t(8;21) − types of anomalies. The most frequent abnormality other than t(8;21) was +8, observed in four patients. group (13 vs 34%, P Ͻ 0.05). Thirteen of the 22 t(8;21) − patients with dyserythropoietic features revealed both dysgranulopoietic and dysmegakaryopoietic ones, and were diagnosed as having AML/TLD. 6 The incidence of TLD in the Table 1 . The mean age of the former group was significantly younger than that of the latter group (37 vs 51, patients, respectively, and the difference in the incidence would not have been significant. However, as eosinophils P Ͻ 0.01), whereas there was no difference in the male:female At least 5% large blast cells have a cell diameter which was at least one and a half times as long as that of small blast cells. were conspicuous in BM in most t(8;21) + patients but were cytochemistry. As a result, it was suggested that recognition of homogeneous pink-colored cytoplasm in mature neutroscarcely seen in many t(8;21) − patients, the 'BM eosinopenia' was defined as less than 1.0% eosinophils of all the nucleated phils is most important. This feature was previously called homogeneous 'salmon' pink cytoplasm by Bitter and co-work-BM cells. In this situation, the incidence of BM eosinopenia in the t(8;21)
+ group was significantly (P Ͻ 0.01) lower than ers. 1 − patients may patients homogeneous pink-colored cytoplasm in mature neutrophils is most characteristic of t(8;21) AML-M2, because it indicate that about half of the patients whose mature neutrophils showed pale-colored cytoplasm had complete agranulwas seen in only one (2%) of the 50 t(8;21) − patients. Accordingly, recognition of the feature may be most important to disarity. On the other hand, homogeneous pink-colored cytoplasm of mature neutrophils of t(8;21) + AML was suggestive tinguish t(8;21) AML based on cell morphology. Conversely, recognition of pale-colored cytoplasm without any granules of the presence of microgranules in most patients, because the MPO-deficient mature neutrophils were seen in only 13% of in mature neutrophils or dyserythropoietic features may be helpful to distinguish AML-M2 without t(8;21), since at least the t(8;21) + group. This hypothesis must be tested by using an electron microscopic method. one of them was observed in 42 (84%) of the 50 t(8;21) − patients but in none of the 30 t(8;21) + patients. There were 11 patients in whom neither characteristically colored cytoplasm in mature neutrophils nor dyserythropoThere were three t(8;21) + and eight t(8;21) − patients in whom neither characteristically colored cytoplasm in mature ietic features were observed, although these features could be most important to predict whether or not AML-M2 patients neutrophils nor dyserythropoietic features were observed. NAP score was available in one of the former and four of the have t(8;21). For these patients, however, NAP score was useful. latter, and the score of the t(8;21) + patient was low (84) In summary, it was suggested that the recognition of homogeneous pink-colored cytoplasm of mature neutrophils is most important to distinguish t(8;21) + patients in AML-M2, and that pale-colored cytoplasm without any granules in mature neutrophils and dyserythropoietic features are the most negative features for the presence of this chromosome anomaly. It is well known that chromosome features have a prognostic value in AML, and that patients with t(8;21), t(15;17), or inv(16) exhibit a good response to chemotherapy with high CR rates and a long DFS. 10 However, cytogenetic results may occasionally be unavailable because metaphase cells are not 
